Draghia-Akli Ruxandra bought NVAX
November 11, 2024 · Form 4 insider transaction
Draghia-Akli Ruxandra bought 64,150 shares of Novavax, Inc. at $9.01 per share, a transaction worth $578.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
64,150
Price
$9.01
Total value
$578.0K
InsiderDraghia-Akli Ruxandra
RoleOfficer
CompanyNovavax, Inc. (NVAX)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateNovember 11, 2024
Filing dateNovember 13, 2024
Shares owned after64,150
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.